Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life?

Dose tailoring of human cell line-derived recombinant factor VIII simoctocog alfa: using a limited sampling strategy in patients with severe haemophilia A

(2019) X. Delavenne et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A

(2019) J.E. Megías-Vericat et al.   THROMBOSIS RESEARCH

Development and evaluation of a generic population pharmacokinetic model for standard half-life factor VIII for use in dose individualization

(2019) Alanna McEneny-King et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Comparative pharmacokinetics of two extended half‐life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: is there a difference?

(2019) M D Carcao et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Application of Size and Maturation Functions to Population Pharmacokinetic Modeling of Pediatric Patients

(2019) Hyun-moon Back et al.   Pharmaceutics

Population Pharmacokinetics Modelling and Simulation of Mitotane in Patients with Adrenocortical Carcinoma: An Individualized Dose Regimen to Target All Patients at Three Months?

(2019) Yoann Cazaubon et al.   Pharmaceutics

Population pharmacokinetics of articaine with 1:200,000 epinephrine during third molar surgery and simulation of high-dose regimens

(2018) Yoann Cazaubon et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement

(2017) A. Iorio et al.   HAEMOPHILIA

Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH

(2017) A. Iorio et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Population pharmacokinetics of recombinant coagulation factor VIII-SingleChain in patients with severe hemophilia A

(2017) Y. Zhang et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

A population pharmacokinetic model for perioperative dosing of factor VIII in hemophilia A patients

(2016) H. Hazendonk et al.   HAEMATOLOGICA

A population pharmacokinetic model for perioperative dosing of factor VIII in hemophilia A patients

(2016) H. Hazendonk et al.   HAEMATOLOGICA

Prediction of Fat-Free Mass in Children

(2015) Hesham Saleh Al-Sallami et al.   CLINICAL PHARMACOKINETICS

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A

(2013) J. Mahlangu et al.   BLOOD

Evaluation of bootstrap methods for estimating uncertainty of parameters in nonlinear mixed-effects models: a simulation study in population pharmacokinetics

(2013) Hoai-Thu Thai et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models

(2011) Martin Bergstrand et al.   AAPS Journal

Pharmacoeconomic impact of obesity in severe haemophilia children on clotting factor prophylaxis in a single institution

(2011) S. MAJUMDAR et al.   HAEMOPHILIA

Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents

(2010) Dieter Klarmann et al.   TRANSFUSION

Population pharmacokinetics of recombinant factor VIII:C (ReFacto®) in adult HIV-negative and HIV-positive haemophilia patients

(2009) Anastasia Karafoulidou et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY